Literature DB >> 25636925

Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001-2011 survey by the French Pneumococcal Network.

M Kempf1, E Varon2, A Lepoutre3, A Gravet1, R Baraduc1, M Brun1, H Chardon1, J Cremniter1, J Croizé1, F Dalmay4, M-C Demachy1, T Fosse1, C Grelaud1, T Hadou1, F Hamdad1, J-L Koeck1, S Luce4, S Mermond1, I Patry1, A Péchinot1, J Raymond1, A Ros1, C Segonds1, B Soullié1, D Tandé1, M Vergnaud1, V Vernet-Garnier1, F Wallet1, L Gutmann2, M-C Ploy1, P Lanotte5.   

Abstract

Streptococcus pneumoniae is an important cause of acute otitis media (AOM). The aim of this study was to evaluate trends in antibiotic resistance and circulating serotypes of pneumococci isolated from middle ear fluid of French children with AOM during the period 2001-2011, before and after the introduction of the PCV-7 (2003) and PCV-13 (2010) vaccines. Between 2001 and 2011 the French pneumococcal surveillance network analysed the antibiotic susceptibility of 6683 S. pneumoniae isolated from children with AOM, of which 1569 were serotyped. We observed a significant overall increase in antibiotic susceptibility. Respective resistance (I+R) rates in 2001 and 2011 were 76.9% and 57.3% for penicillin, 43.0% and 29.8% for amoxicillin, and 28.6% and 13.0% for cefotaxime. We also found a marked reduction in vaccine serotypes after PCV-7 implementation, from 63.0% in 2001 to 13.2% in 2011, while the incidence of the additional six serotypes included in PCV-13 increased during the same period, with a particularly high proportion of 19A isolates. The proportion of some non-PCV-13 serotypes also increased between 2001 and 2011, especially 15A and 23A. Before PCV-7 implementation, most (70.8%) penicillin non-susceptible pneumococci belonged to PCV-7 serotypes, whereas in 2011, 56.8% of penicillin non-susceptible pneumococci belonged to serotype 19A. Between 2001 and 2011, antibiotic resistance among pneumococci responsible for AOM in France fell markedly, and PCV-7 serotypes were replaced by non-PCV-7 serotypes, especially 19A. We are continuing to assess the impact of PCV-13, introduced in France in 2010, on pneumococcal serotype circulation and antibiotic resistance.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; French regional observatories; Streptococcus pneumoniae; pneumococcal vaccine

Mesh:

Substances:

Year:  2014        PMID: 25636925     DOI: 10.1016/j.cmi.2014.08.009

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

Review 1.  The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.

Authors:  Robert Cohen; Sandra Biscardi; Corinne Levy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Directed vaccination against pneumococcal disease.

Authors:  Yi Li; Andrew Hill; Marie Beitelshees; Shuai Shao; Jonathan F Lovell; Bruce A Davidson; Paul R Knight; Anders P Hakansson; Blaine A Pfeifer; Charles H Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

3.  Corrigendum.

Authors: 
Journal:  Hum Vaccin Immunother       Date:  2016-09       Impact factor: 3.452

4.  Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children.

Authors:  C Hays; Q Vermee; A Agathine; A Dupuis; E Varon; C Poyart; M-C Ploy; J Raymond
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-20       Impact factor: 3.267

5.  Mastoiditis with Streptococcus pneumoniae serotype 19A in one-dose PCV13 vaccinated three-month-old infant.

Authors:  B Gülhan; S Kanik-Yuksek; A Ozkaya-Parlakay
Journal:  Hum Vaccin Immunother       Date:  2019-07-26       Impact factor: 3.452

Review 6.  Panel 6: Vaccines.

Authors:  Melinda M Pettigrew; Mark R Alderson; Lauren O Bakaletz; Stephen J Barenkamp; Anders P Hakansson; Kevin M Mason; Johanna Nokso-Koivisto; Janak Patel; Stephen I Pelton; Timothy F Murphy
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

7.  Dramatic decrease of Streptococcus pneumoniae infections in Marseille, 2003-2014.

Authors:  C Abat; D Raoult; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-26       Impact factor: 3.267

8.  Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain.

Authors:  María Morales; Guillermo Ludwig; Maria Ercibengoa; Cristina Esteva; Viviana Sanchez-Encinales; Marta Alonso; Carmen Muñoz-Almagro; José Maria Marimón
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

9.  Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016-2019.

Authors:  Esra Ekinci; Stefanie Desmet; Liesbet Van Heirstraeten; Colette Mertens; Ine Wouters; Philippe Beutels; Jan Verhaegen; Surbhi Malhotra-Kumar; Heidi Theeten
Journal:  Front Pediatr       Date:  2021-07-05       Impact factor: 3.418

10.  Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017.

Authors:  Kimiko Ubukata; Misako Takata; Miyuki Morozumi; Naoko Chiba; Takeaki Wajima; Shigeo Hanada; Michi Shouji; Megumi Sakuma; Satoshi Iwata
Journal:  Emerg Infect Dis       Date:  2018-11       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.